+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cefotaxime"

Cephalosporin Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cephalosporin Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 195 Pages
  • Global
From
Cephalosporin Drugs Market Report 2025 - Product Thumbnail Image

Cephalosporin Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cephalosporin Drugs - Global Strategic Business Report - Product Thumbnail Image

Cephalosporin Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 398 Pages
  • Global
From
Urinary Tract Infection Treatment Market Report 2025 - Product Thumbnail Image

Urinary Tract Infection Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Antibacterial Drugs Market Report 2024-2034 - Product Thumbnail Image

Antibacterial Drugs Market Report 2024-2034

  • Report
  • January 2024
  • 269 Pages
  • Global
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2024
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2024
  • 135 Pages
  • China
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Cefotaxime is a third-generation cephalosporin antibiotic used to treat a wide range of bacterial infections. It is commonly used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. Cefotaxime is also used to treat meningitis, septicemia, and endocarditis. It is effective against both Gram-positive and Gram-negative bacteria. Cefotaxime is available in both intravenous and intramuscular forms. Cefotaxime is part of the larger market of antibiotics, which are used to treat bacterial infections. Antibiotics are a major component of modern medicine, and are used to treat a wide range of bacterial infections. The market for antibiotics is highly competitive, with many different companies offering a variety of products. Some of the companies in the Cefotaxime market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and AstraZeneca. Show Less Read more